Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.PH)

PIRS.PH on Philadelphia Stock Exchange

2.93USD
17 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.93
Open
--
Day's High
--
Day's Low
--
Volume
20
Avg. Vol
908
52-wk High
$6.90
52-wk Low
$2.41

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $142.05
Shares Outstanding(Mil.): 49.15
Dividend: --
Yield (%): --

Financials

  PIRS.PH Industry Sector
P/E (TTM): -- 103.27 57.80
EPS (TTM): -0.51 -- --
ROI: -35.35 7.81 11.82
ROE: -103.98 7.87 12.64

Earnings vs. Estimates